BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 33025856)

  • 1. Identification of Hub Genes in Anaplastic Thyroid Carcinoma: Evidence From Bioinformatics Analysis.
    Li L; Zhu M; Huang H; Wu J; Meng D
    Technol Cancer Res Treat; 2020; 19():1533033820962135. PubMed ID: 33025856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
    Hu S; Liao Y; Chen L
    Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated Bioinformatics Analysis of Master Regulators in Anaplastic Thyroid Carcinoma.
    Pan Z; Li L; Fang Q; Qian Y; Zhang Y; Zhu J; Ge M; Huang P
    Biomed Res Int; 2019; 2019():9734576. PubMed ID: 31183379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of key candidate genes and pathways in anaplastic thyroid cancer by bioinformatics analysis.
    Ding YG; Ren YL; Xu YS; Wei CS; Zhang YB; Zhang SK; Guo CA
    Am J Otolaryngol; 2020; 41(3):102434. PubMed ID: 32093976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of Key Genes in Human Anaplastic Thyroid Cancer via the Weighing Gene Coexpression Network.
    Gong Y; Xu F; Deng L; Peng L
    Biomed Res Int; 2022; 2022():2244228. PubMed ID: 35782055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TMEM158 May Serve as a Diagnostic Biomarker for Anaplastic Thyroid Carcinoma: An Integrated Bioinformatic Analysis.
    Li HN; Du YY; Xu T; Zhang R; Wang G; Lv ZT; Li XR
    Curr Med Sci; 2020 Dec; 40(6):1137-1147. PubMed ID: 33428142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of hub genes and pathways in adrenocortical carcinoma by integrated bioinformatic analysis.
    Guo J; Gu Y; Ma X; Zhang L; Li H; Yan Z; Han Y; Xie L; Guo X
    J Cell Mol Med; 2020 Apr; 24(8):4428-4438. PubMed ID: 32147961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses.
    Wu J; Lv Q; Huang H; Zhu M; Meng D
    Genet Test Mol Biomarkers; 2020 Aug; 24(8):484-491. PubMed ID: 32598242
    [No Abstract]   [Full Text] [Related]  

  • 9. Integrated analysis of transcriptome data revealed MMP3 and MMP13 as critical genes in anaplastic thyroid cancer progression.
    Ma Y; Cang S; Li G; Su Y; Zhang H; Wang L; Yang J; Shi X; Qin G; Yuan H
    J Cell Physiol; 2019 Dec; 234(12):22260-22271. PubMed ID: 31081124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of key genes and pathways of thyroid cancer by integrated bioinformatics analysis.
    Liu L; He C; Zhou Q; Wang G; Lv Z; Liu J
    J Cell Physiol; 2019 Dec; 234(12):23647-23657. PubMed ID: 31169306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of key pathways and biomarkers in anaplastic thyroid cancer using an integrated analysis.
    Zhou J; Dong S; Shi C
    J BUON; 2020; 25(6):2690-2699. PubMed ID: 33455115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
    Liu X; Liu X; Li J; Ren F
    Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of candidate aberrantly methylated and differentially expressed genes in Esophageal squamous cell carcinoma.
    Han BA; Yang XP; Hosseini DK; Zhang P; Zhang Y; Yu JT; Chen S; Zhang F; Zhou T; Sun HY
    Sci Rep; 2020 Jun; 10(1):9735. PubMed ID: 32546690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genes and pathways identified in thyroid carcinoma based on bioinformatics analysis.
    Yu JW; Mai W; Cui YL; Kong LY
    Neoplasma; 2016; 63(4):559-68. PubMed ID: 27268919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Identification of key pathways and drug repurposing for anaplastic thyroid carcinoma by integrated bioinformatics analysis].
    Pan Z; Fang Q; Zhang Y; Li L; Huang P
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 May; 47(2):187-193. PubMed ID: 30226315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification for Exploring Underlying Pathogenesis and Therapy Strategy of Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
    Xu Z; Jiang P; He S
    Med Sci Monit; 2019 Dec; 25():9216-9226. PubMed ID: 31794546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.